Globus Medical raises full-year EPS guidance.

Globus Medical raises full-year EPS guidance. Medical device maker Globus Medical lifted its 2026 non-GAAP earnings per share guidance to $4.70-$4.80, up from prior expectations, following strong Q1 results. The company reported first quarter revenue of $759.9 million with earnings per share of $1.12, while reaffirming its full-year revenue guidance of $3.18 billion to $3.22 billion. The guidance increase reflects confidence in operational execution and market demand for its orthopedic and spine solutions. Investors should monitor the company's robotics lease mix strategy and potential integration challenges from its Nevro acquisition as key factors that could impact future performance and profitability targets.